Press Releases

DR Systems (www.drsys.com), a leader in healthcare imaging and information technologies, was recently named one of the largest vendors of electronic health record (EHR) systems in the U.S. by Modern Healthcare, a major healthcare research and media company.

New version of Siemens’ established digital imaging solution offers two-detector X-ray technology for smaller budgets

Outcomes of International Multi-Center Trial Sponsored by Toshiba Published in American Journal of Roentgenology

Fort Lee, New Jersey, January 8, 2015 – Rayence Inc. announced the appointment of Bill Cioffi as Vice President of Business Development. Cioffi, an industry veteran who spent the majority of 35 year career in management positions at Fujifilm Medical Systems and later Del Medical, joined Rayence in mid-2014 as Director of Sales and Marketing.

Papworth Hospital NHS Foundation Trust has officially unveiled a SOMATOM® Force in its Radiology Department to bolster its cardiac imaging services. The new technology was launched by Cambridge MP Dr Julian Huppert at the official opening of the system. The CT imaging system will benefit patients by using the lowest achievable dose and provide patients who suffer with shortness of breath with rapid scanning. With approximately half of all the hospital’s CT imaging consisting of cardiac procedures, it is anticipated the system will increase cardiac throughput.

Expanded use of Gadavist is specific to detecting and visualizing areas with disrupted blood brain barrier and/or abnormal vascularity of the central nervous system in pediatric patients under the age of 2 yearsApproval based on data demonstrating the pharmacokinetic and safety profiles of Gadavist at standard dose (0.1 mmol/kg) were similar to adults and to children 2 years of age and olderU.S. Food and Drug Administration (FDA) granted priority review designation for Gadavist (gadobutrol) for this population

WINTER SPRINGS, Fla., Dec. 22, 2014 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (Nasdaq:IRMD), the only provider of non-magnetic intravenous (IV) infusion pump systems for use during magnetic resonance imaging (MRI) procedures, announced today that it has resumed domestic distribution of its MRI compatible MRidium 3860 IV infusion pump systems.

FUJIFILM Diosynth Biotechnologies U.S.A. Inc. (FDBU), a FUJIFILM Corporation subsidiary, today announced the completion of its acquisition of Kalon Biotherapeutics LLC, marking an important new chapter in the emergence of the Texas biosciences industry as a center for world-class development and manufacturing of life-saving biopharmaceuticals and biotechnology while providing FUJIFILM Diosynth Biotechnologies with expanded capacity for its growing vaccine capabilities. The completion of the previously announced Purchase Interest Agreement of Kalon Biotherapeutics, LLC, was made with the owners of Kalon: the State of Texas, acting by and through the Office of the Governor, and The Texas A&M University System. The announcement was made jointly today by Governor Rick Perry; officials of FUJIFILM Corporation, FDBU and Mitsubishi Corporation; Kalon Biotherapeutics LLC; and the Texas A&M System. Going forward, the company is now known as FUJIFILM Diosynth Biotechnologies Texas, LLC.

Groundbreaking approach to clinical trials should improve access to promising drugs for lung cancer patients.

Witham Health Services (Lebanon, Ind.) recently installed a CARESTREAM Vue Cardio PACS with a zero-footprint viewer that allows on-site or remote clinicians, cardiologists and referring physicians to access imaging data, reports and patient information. This viewer utilizes a native browser and supports smart phone and tablet mobile devices.  

Royal Philips (NYSE: PHG; AEX: PHIA) and Volcano Corporation (NASDAQ:VOLC), a global leader in catheter-based imaging and measurement solutions for cardiovascular applications, today announced that they have entered into a definitive merger agreement. Pursuant to the agreement, Philips will commence a tender offer to acquire all of the issued and outstanding shares of Volcano for USD 18.00 per share, or a total equity purchase price of USD 1 billion (approx. EUR 800 million), to be paid in cash upon completion. The board of directors of Volcano has unanimously approved the transaction and recommends the offer to its shareholders. The transaction is expected to close in the first quarter of 2015.

Millions of imaging tests are performed in the United States each year.  Although most of these exams are interpreted by a radiologist, patients usually receive their results from the ordering physician.  In many cases, the radiologist, as the imaging expert, is actually the physician best equipped to explain imaging findings. Lightbulb Radiology bridges this gap between the radiologist and the patient.

InnoLife, a consortium of 144 European companies, research institutes and universities, has been selected by the European Institute of Innovation and Technology (EIT) as the Knowledge and Innovation Community (KIC) for EIT Health. With a total volume of EUR 2.1 billion it is one of the largest public funded initiatives for health worldwide.

Definiens, the global leader in Tissue Phenomics® for oncology diagnostics, today announced the newest version of its leading image analysis software for quantitative digital pathology, Tissue Studio 4.0. The new release provides greater flexibility, more accurate and consistent results, and the ability to use any chromogen for single and dual stain immunohistochemistry (IHC) quantification.

Mobile X-ray imaging systems are essential tools for surgeons who want to view the positioning of medical devices or evaluate the progress of a variety of corrective procedures. Surgeons on the medical staff of Baylor University Medical Center (Dallas, Texas) now have access to high-quality images in as little as five seconds thanks to the implementation of two CARESTREAM DRX-Revolution Mobile X-ray Systems. These systems are moved from patient to patient as needed in the hospital’s 56-bed surgical suite.

Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that it has reached the planned enrollment of 1,200 patients in the PROSPECT Phase 3 clinical study of its targeted active immunotherapy candidate, PROSTVAC®, in the treatment of asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC). Patients were enrolled at 214 sites in 15 countries.

TeraRecon, (www.terarecon.com), a leader in advanced visualization and enterprise medical image viewing solutions, highlighted major implementation and innovations of its iNtuition advanced visualization solution combined with its new iNteract+ interoperability capabilities, at the 100th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), held at McCormick Place, Chicago, Illinois, November 30th-Dec 4th, 2014. 

GI View Ltd., developer of advanced GI screening systems, announced today that it has received FDA 510(k) clearance for its flagship product, the Aer-O-Scope™ Colonoscope System, an advanced, comprehensive and easy-to-use system for colorectal cancer screening.  Market introduction is expected in the U.S. in early 2016.

Viztek, the leading provider of complete digital software and hardware diagnostic imaging solutions, today announced upgraded features that have been added to its Exa PACS.

 Royal Philips (NYSE: PHG, AEX: PHIA) today announced the launch of Ingenia 1.5T S, a new MR system designed for "First Time Right" imaging and for faster workflow, while enhancing the patient's experience during magnetic resonance imaging (MRI) examinations. The system joins Philips' global portfolio of diagnostic imaging solutions designed to enhance imaging quality and help providers manage workflow efficiency.

Sorna Corporation, a global leader in digital medical image and data sharing systems, announced today that its latest software innovation, Vertex, is officially released and shipping. Vertex is the industry’s most advanced software for sharing, burning, importing, converting, viewing, and storing medical images and related documents.